1991
DOI: 10.1016/s1043-6618(05)80120-3
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of beta-endorphin/beta-lipotropin immunoreactivity content in the CSF of patients affected by deafferentation pain syndromes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1992
1992
2008
2008

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 10 publications
(1 citation statement)
references
References 23 publications
0
1
0
Order By: Relevance
“…Furthermore, the endorphin-like immunoreactivity in the cerebrospinal fluid was lower in the patients with neuropathic pain than in those experiencing other kinds of pain [47]. On the other hand, no significant variation in the levels of β-endorphin was found in patients suffering from deafferentation pain [48].…”
Section: Opioids Systems In Nociception and Neuropathic Pain εNdorphinsmentioning
confidence: 84%
“…Furthermore, the endorphin-like immunoreactivity in the cerebrospinal fluid was lower in the patients with neuropathic pain than in those experiencing other kinds of pain [47]. On the other hand, no significant variation in the levels of β-endorphin was found in patients suffering from deafferentation pain [48].…”
Section: Opioids Systems In Nociception and Neuropathic Pain εNdorphinsmentioning
confidence: 84%